viatel™ ultrapure bioresorbable polymers
chemistry: bioresorbable polymers
chemical name: Poly D,L lactide-co-glycolide (PLGA) / Poly D,L lactide (PDLLA)
SDS Link >- overview
- literature & videos
- technical studies
- regulatory/compliance
Viatel™ Ultrapure high-purity bioresorbable polymers for long-acting injectables and implants offer improved stability and achieve longer, more consistent drug release profiles; they are better suited for sensitive drug compounds in long-acting injectables and implants (LAII).
Removing residual monomer reduces acidic equivalents and results in a more consistent rate of water uptake and degradation kinetics. This means more reproducible performance while also creating a more neutral pH environment. Viatel™ Ultrapure polymers leverage a proprietary purification process that reduces total residual monomer content specifications to below 0.5% with typical batch results of approximately 0.1%. Furthermore, these polymers are pre-filtered during the purification process to ensure exceptional quality.
These low-monomer products are available as GMP grades across the Viatel™ platform and provide formulators greater versatility when solving challenging formulation problems.
Viatel™ Ultrapure polymers are the result of Ashland’s commitment to continuous improvement in response to customer needs.
read more >
features and benefits - lowered residual monomer content: ≤ 0.5% total, typical batch results of 0.1%
- reduced tin content (catalyst) is available upon request
- pre-filtered polymer to remove the risk of impurities or foreign particles
- reduced acidity leading to improved stability of sensitive drug compounds
- improved release consistency across all applications due to fewer variables
- extended-release with hot melt
- extrusion applications
- faster solubilization in organic solvents
applications - tissue engineering scaffolds
- dermal fillers
- orthopedic implants
region currently available
For country-specific details, please contact your local sales representative.
Asia Pacific / China / Europe Middle East & Africa / Latin America / North America
additional content coming soon
additional content coming soon
bioresorbable polymers
A scalable technology platform with multiple applications, bioresorbable polymers serve as a vital component to long-acting injectables and provide a controlled release matrix to address chronic disease, patient compliance, and animal health.
For advanced drug delivery, bioresorbable polymers serve as a carrier that improves the delivery of mRNA to cells, and when it comes to medical devices and regenerative medicine, bioresorbable polymers function as degradable devices and fillers for a wider range of dermal fillers, sutures, screws vital to surgical procedures in every market of the world.
The platform can best be seen by visiting Ashland’s newly launched viatel™ ultrapure bioresorbable polymers.
Ashland has made a major capacity investment for bioresorbable polymers.
